study	individual	group	count	intervention	measurement_type	substance	tissue	method	label	time	time_unit	value	mean	mean_pm	mean_sd	mean_se	comments	mean_unit	value_unit
FDA1995		all	12.0	GLI1po	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1po	0.0	hr		0.0					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1po	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1po	2.0	hr		0.07301401869158879					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1po	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1po	4.0	hr		0.2839434060228446					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1po	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1po	8.0	hr		0.6192668823685845					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1po	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1po	12.0	hr		0.7707035306334366					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1po	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1po	24.0	hr		0.9572949117341628					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1po	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1po	48.0	hr		0.9735202492211837					count*mole/kilogram	percent
